This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): XPro1595
Description: XPro1595 is a dominant negative inhibitor of TNF alpha.
XPro1595 was discovered and developed at Xencor.
In April 2012, FPRT Bio entered into a world-wide license agreement for the use of XPro1595 from Xencor.
Partners: Xencor, Inc.
Pink Sheet Xencor Set To Spruce Up Pfizer Antibodies
Additional information available to subscribers only: